Dostarlimab-Gxly 500 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500 mg
Reference Brands: Jemperli(USA/EU)
Category: Oncology Cancer Care
Dostarlimab is a humanized monoclonal antibody that targets PD‑1 on T cells, blocking its interaction with PD‑L1/PD-L2. This releases the “brake” on the immune system, allowing T cells to attack cancer cells. It is used mainly for mismatch repair–deficient (dMMR) endometrial cancer and certain other solid tumors with dMMR.
Dostarlimab-Gxly — third party manufacturing & bulk supply
Dostarlimab-Gxly 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Dostarlimab-Gxly is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Dostarlimab-Gxly listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Dostarlimab-Gxly →Frequently Asked Questions
Dostarlimab-gxly is used for the treatment of certain advanced or recurrent endometrial cancers that are mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H). It helps the immune system recognize and attack cancer cells by blocking the PD-1 receptor.
It is made from a monoclonal antibody that selectively binds to the programmed death-1 (PD-1) receptor on T-cells, preventing tumor cells from evading immune detection.
The trade name is Jemperli.
Jemperli is manufactured by GlaxoSmithKline (GSK).
The generic name is Dostarlimab-gxly.
The brand name is Jemperli.
It is manufactured by GlaxoSmithKline in its approved biologics production facilities for global distribution.
Related Products
Mitomycin Pyelocalyceal
Strength:
40 mg
Form: Injection
Reference Brands: Jelmyto (USA/EU)
View Details
Fludarabine Phosphate
Strength:
Injection: 25 mg/ml; Tablet: 10 mg
Form: Injection (IV), Oral Tablet
Reference Brands: Fludara® (US & EU)
View Details
Fosaprepitant Dimeglumine
Strength:
150 mg/vial
Form: Injection (IV)
Reference Brands: Emend® IV (EU & US)
View Details
Fulvestrant
Strength:
250 mg/5 mL
Form: Injection
Reference Brands: Faslodex (EU & US),Fulzos (India)
View Details
Gemcitabine
Strength:
200 mg, 1000 mg, 1500 mg
Form: Lyophilized powder for solution for injection/infusion
Reference Brands: Gemzar® (US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
